RU2255090C2 - Стероидные соединения, способ селективной модификации, фармацевтическая композиция - Google Patents
Стероидные соединения, способ селективной модификации, фармацевтическая композиция Download PDFInfo
- Publication number
- RU2255090C2 RU2255090C2 RU2002135594/04A RU2002135594A RU2255090C2 RU 2255090 C2 RU2255090 C2 RU 2255090C2 RU 2002135594/04 A RU2002135594/04 A RU 2002135594/04A RU 2002135594 A RU2002135594 A RU 2002135594A RU 2255090 C2 RU2255090 C2 RU 2255090C2
- Authority
- RU
- Russia
- Prior art keywords
- steroid
- compound according
- estrogen receptors
- compound
- compounds
- Prior art date
Links
- 0 C[C@](CC1C=C)(C(C[C@]2CCC(*)(CC3)O)C(C(*)C(*)c4c5)C1c4ccc5O)[C@@]23O Chemical compound C[C@](CC1C=C)(C(C[C@]2CCC(*)(CC3)O)C(C(*)C(*)c4c5)C1c4ccc5O)[C@@]23O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201986 | 2000-06-06 | ||
| EP00201986.7 | 2000-06-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2002135594A RU2002135594A (ru) | 2004-09-20 |
| RU2255090C2 true RU2255090C2 (ru) | 2005-06-27 |
Family
ID=8171601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002135594/04A RU2255090C2 (ru) | 2000-06-06 | 2001-05-01 | Стероидные соединения, способ селективной модификации, фармацевтическая композиция |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US7868193B2 (OSRAM) |
| EP (1) | EP1294739B1 (OSRAM) |
| JP (1) | JP5095902B2 (OSRAM) |
| KR (1) | KR100769865B1 (OSRAM) |
| CN (1) | CN1235908C (OSRAM) |
| AR (1) | AR028080A1 (OSRAM) |
| AT (1) | ATE293124T1 (OSRAM) |
| AU (2) | AU5838601A (OSRAM) |
| BR (1) | BR0111445A (OSRAM) |
| CA (1) | CA2410220C (OSRAM) |
| CZ (1) | CZ20024014A3 (OSRAM) |
| DE (1) | DE60110069T2 (OSRAM) |
| DK (1) | DK1294739T3 (OSRAM) |
| ES (1) | ES2240454T3 (OSRAM) |
| HU (1) | HUP0301190A3 (OSRAM) |
| IL (1) | IL152957A0 (OSRAM) |
| MX (1) | MXPA02012117A (OSRAM) |
| NO (1) | NO324247B1 (OSRAM) |
| PE (1) | PE20020214A1 (OSRAM) |
| PL (1) | PL203732B1 (OSRAM) |
| PT (1) | PT1294739E (OSRAM) |
| RU (1) | RU2255090C2 (OSRAM) |
| SK (1) | SK286852B6 (OSRAM) |
| TW (1) | TWI225068B (OSRAM) |
| WO (1) | WO2002000682A1 (OSRAM) |
| ZA (1) | ZA200209452B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201109346A (en) * | 2009-06-10 | 2011-03-16 | Organon Nv | Substituted 16,17-annellated steroid compounds for use in women's healthcare |
| US8367648B2 (en) | 2009-06-10 | 2013-02-05 | Msd Oss B.V. | Substituted 16,17-annellated steroid compounds for use in womens healthcare |
| CN121203937A (zh) * | 2025-11-26 | 2025-12-26 | 长春中医药大学 | 一种人参不定根细胞株CCUM-Re-7及其提取物与制备方法、应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194821A (en) * | 1963-12-30 | 1965-07-13 | Abbott Lab | 17alpha-substituted 17beta-hydroxyestrenes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
| IL123195A (en) * | 1997-02-21 | 2002-11-10 | Akzo Nobel Nv | Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them |
-
2001
- 2001-04-17 TW TW090109186A patent/TWI225068B/zh not_active IP Right Cessation
- 2001-05-01 DK DK01931676T patent/DK1294739T3/da active
- 2001-05-01 KR KR1020027016657A patent/KR100769865B1/ko not_active Expired - Fee Related
- 2001-05-01 ES ES01931676T patent/ES2240454T3/es not_active Expired - Lifetime
- 2001-05-01 CA CA002410220A patent/CA2410220C/en not_active Expired - Fee Related
- 2001-05-01 AT AT01931676T patent/ATE293124T1/de active
- 2001-05-01 PL PL359238A patent/PL203732B1/pl not_active IP Right Cessation
- 2001-05-01 CN CNB018107451A patent/CN1235908C/zh not_active Expired - Fee Related
- 2001-05-01 RU RU2002135594/04A patent/RU2255090C2/ru not_active IP Right Cessation
- 2001-05-01 EP EP01931676A patent/EP1294739B1/en not_active Expired - Lifetime
- 2001-05-01 AU AU5838601A patent/AU5838601A/xx active Pending
- 2001-05-01 MX MXPA02012117A patent/MXPA02012117A/es active IP Right Grant
- 2001-05-01 WO PCT/EP2001/004868 patent/WO2002000682A1/en not_active Ceased
- 2001-05-01 PT PT01931676T patent/PT1294739E/pt unknown
- 2001-05-01 IL IL15295701A patent/IL152957A0/xx not_active IP Right Cessation
- 2001-05-01 DE DE60110069T patent/DE60110069T2/de not_active Expired - Lifetime
- 2001-05-01 BR BR0111445-0A patent/BR0111445A/pt not_active IP Right Cessation
- 2001-05-01 AU AU2001258386A patent/AU2001258386B2/en not_active Ceased
- 2001-05-01 HU HU0301190A patent/HUP0301190A3/hu unknown
- 2001-05-01 US US10/297,706 patent/US7868193B2/en not_active Expired - Fee Related
- 2001-05-01 CZ CZ20024014A patent/CZ20024014A3/cs unknown
- 2001-05-01 SK SK1707-2002A patent/SK286852B6/sk not_active IP Right Cessation
- 2001-05-01 JP JP2002505804A patent/JP5095902B2/ja not_active Expired - Fee Related
- 2001-05-03 PE PE2001000401A patent/PE20020214A1/es not_active Application Discontinuation
- 2001-05-04 AR ARP010102107A patent/AR028080A1/es unknown
-
2002
- 2002-11-20 ZA ZA200209452A patent/ZA200209452B/en unknown
- 2002-12-02 NO NO20025793A patent/NO324247B1/no not_active IP Right Cessation
-
2010
- 2010-06-15 US US12/816,058 patent/US20100249083A1/en not_active Abandoned
-
2011
- 2011-05-20 US US13/112,184 patent/US20110224183A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194821A (en) * | 1963-12-30 | 1965-07-13 | Abbott Lab | 17alpha-substituted 17beta-hydroxyestrenes |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1272504B1 (de) | 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene | |
| DE60025817T2 (de) | Ent-steroide als selektiv wirksame estrogene | |
| EP1144431A2 (de) | 16-hydroxyestratriene als selektiv wirksame estrogene | |
| US5502046A (en) | 11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents | |
| US20110224183A1 (en) | 16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity | |
| EP1226155A2 (de) | 18-nor-steroide als selektiv wirksame estrogene | |
| US6881728B1 (en) | 14-β, 17-α-hydroxymethylandrostane derivatives as androgens | |
| DE10019167A1 (de) | Substituierte Estratriene als selektiv wirksame Estrogene | |
| AU2001258386A1 (en) | 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity | |
| WO2000059897A2 (en) | Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds | |
| SK882003A3 (en) | 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use | |
| HK1052012B (en) | 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity | |
| DE19954105A1 (de) | 18-Nor-Steroide als selektiv wirksame Estrogene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC4A | Invention patent assignment |
Effective date: 20070416 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110502 |